Genocea Biosciences reported $-15978000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US $ -48.32M 17.19M
Baxter International BAX:US $ 71M 167M
Cytokinetics CYTK:US $ -89.44M 58.88M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Glaxosmithkline GSK:US $ 1802M 1053M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Merk MRK:US $ 4310M 552M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Moderna Inc MRNA:US 3.66B 1.21B
Novavax NVAX:US $ 203.41M 1049.69M
Pfizer PFE:US $ 7863M 4470M
Prothena PRTA:US $ -36.29M 3.11M